• Home >
  • Vital Signs The Analyst's Perspective - May 2016 Issue

Vital Signs The Analyst's Perspective - May 2016 Issue

30-Jun-2016  /  Research Code: 9A35-00-4C-00-00  /  SKU: HC02651-GL-MR_18709  /  
Region: Global

USD 450.00

* Required Fields

USD 450.00

PAY BY INVOICE

Be the first to review this product

This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

Table of Contents

Vital Signs The Analyst's Perspective - May 2016 IssueVital Signs - May 2016 IssueMay 2016 Issue




Keyword1

Keyword2

Keyword3

Related Research

Why Now is The Time for Interoperable Healthcare Solutions?

Release Date : 05-Jul-18

Region : Global

2018 Top Technologies in Health & Wellness

Release Date : 30-Apr-18

Region : Global

Global Laboratory Products Purchasing Trends, 2017–2018

Release Date : 15-Feb-18

Region : Global

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Release Date : 06-Feb-18

Region : Global

Emerging Sensor Technologies Transforming Medical Diagnostics

Release Date : 29-Dec-17

Region : Global

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.